{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:11:55Z","timestamp":1791400315406,"version":"4.3.3"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.bcp.2006.10.031","type":"journal-article","created":{"date-parts":[[2006,11,4]],"date-time":"2006-11-04T12:14:00Z","timestamp":1162642440000},"page":"1084-1096","source":"Crossref","is-referenced-by-count":120,"title":["Histamine H3 receptor antagonists: From target identification to drug leads"],"prefix":"10.1016","volume":"73","author":[{"given":"P.","family":"Bonaventure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Letavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dugovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Aluisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pudiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lovenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2006.10.031_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1113\/jphysiol.1910.sp001392","article-title":"Chemical structure and sympathomimetic action of amines","volume":"41","author":"Barger","year":"1911","journal-title":"J Physiol (London)"},{"key":"10.1016\/j.bcp.2006.10.031_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1966.tb01674.x","article-title":"Receptors mediating some action of histamine","volume":"27","author":"Ash","year":"1966","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.bcp.2006.10.031_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","article-title":"Definition and antagonism of histamine H2-receptors","volume":"236","author":"Black","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.10.031_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/253362a0","article-title":"H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices","volume":"253","author":"Baudry","year":"1975","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2006.10.031_bib5","first-page":"447","article-title":"Development of histaminergic systems in the newborn rat brain","volume":"62","author":"Schwartz","year":"1970","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.bcp.2006.10.031_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bcp.2006.10.031_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.10.031_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/327117a0","article-title":"Highly potent and selective ligands for histamine H3-receptors","volume":"327","author":"Arrang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.10.031_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","article-title":"International Union of Pharmacology. XIII. Classification of histamine receptors","volume":"49","author":"Hill","year":"1997","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2006.10.031_bib10","first-page":"127","article-title":"The histamine H3-receptor. A target for developing new drugs","volume":"39","author":"Leurs","year":"1992","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bcp.2005.10.033","article-title":"The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists\/inverse agonists","volume":"71","author":"Hancock","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0079-6468(05)44405-7","article-title":"Recent medicinal chemistry of the histamine H3 receptor","volume":"44","author":"Letavic","year":"2006","journal-title":"Prog Med Chem"},{"key":"10.1016\/j.bcp.2006.10.031_bib13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S1359-6446(05)03625-1","article-title":"Keynote review: histamine H3 receptor antagonists reach out for the clinic","volume":"10","author":"Celanire","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bcp.2006.10.031_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tips.2004.10.003","article-title":"The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders","volume":"25","author":"Passani","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2006.10.031_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/13543784.14.3.223","article-title":"Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists\/inverse agonists","volume":"14","author":"Hancock","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2006.10.031_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0022-3565(24)39297-3","article-title":"Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles","volume":"293","author":"Lovenberg","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","article-title":"Timmerman H, de Esch IJP. The histamine H3 receptor: from gene cloning to H3 receptor drugs","volume":"4","author":"Leurs","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2006.10.031_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(03)01635-2","article-title":"Molecular and pharmacological characterization of the mouse histamine H3 receptor","volume":"467","author":"Chen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib21","first-page":"L3","article-title":"Cloning of the guinea pig H3 receptor","volume":"11","author":"Cassar","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2006.10.031_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1021\/jm980310g","article-title":"Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists","volume":"42","author":"Ali","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2006.10.031_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703712","article-title":"Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain","volume":"131","author":"Ligneau","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00011-004-1286-9","article-title":"Histamine H3-receptor isoforms","volume":"53","author":"Bakker","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0028-3908(02)00041-2","article-title":"Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor","volume":"42","author":"Wellendorph","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2006.10.031_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s007020200036","article-title":"Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations","volume":"109","author":"Wiedemann","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2006.10.031_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0169-328X(00)00217-5","article-title":"Alternative splicing of the histamine H3 receptor mRNA at the third cytoplasmic loop is not detectable in humans","volume":"83","author":"Liu","year":"2000","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3565(24)29209-0","article-title":"Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists","volume":"299","author":"Wieland","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bjp.0704490","article-title":"Histamine H3-receptor-mediated [35S]GTPg[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors","volume":"135","author":"Rouleau","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","article-title":"High constitutive activity of native H3 receptors regulates histamine neurons in brain","volume":"408","author":"Morisset","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.10.031_bib31","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.1932276100","article-title":"Protean agonism at histamine H3 receptors in vitro and in vivo","volume":"100","author":"Gbahou","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2006.10.031_bib32","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/jm00119a026","article-title":"Synthesis of (aryloxy)alkylamines. 2. Novel imidazo-fused heterocycles with calcium channel blocking and local anesthetic activity","volume":"31","author":"Sanfilippo","year":"1988","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2006.10.031_bib33","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/jm030185v","article-title":"A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines","volume":"46","author":"Apodaca","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2006.10.031_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjp.0705964","article-title":"Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist","volume":"143","author":"Barbier","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)37840-1","article-title":"Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist","volume":"287","author":"Ligneau","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib36","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1523\/JNEUROSCI.22-17-07695.2002","article-title":"Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep\u2013wake control","volume":"22","author":"Parmentier","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2006.10.031_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diabetes.50.2.376","article-title":"Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2006.10.031_bib38","first-page":"87","article-title":"Possible roles of brain histamine H3 receptors and the pharmacology of its ligands","volume":"15","author":"Onodera","year":"1995","journal-title":"Nippon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/j.bcp.2006.10.031_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0024-3205(01)01138-9","article-title":"The H3 receptor is involved in cholecystokinin inhibition of food intake in rats","volume":"69","author":"Attoub","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2006.10.031_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-3223(98)00044-4","article-title":"A histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats","volume":"45","author":"Itoh","year":"1999","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.bcp.2006.10.031_bib41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI15784","article-title":"Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype","volume":"110","author":"Takahashi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2006.10.031_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.62.2.389","article-title":"Behavioral characterization of mice lacking histamine H3 receptors","volume":"62","author":"Toyota","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib43","first-page":"A29","article-title":"The effect of leptin on sleep is absent in histamine-3 receptor deficient mice","volume":"29","author":"Laposky","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.bcp.2006.10.031_bib44","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.2337\/diabetes.48.12.2286","article-title":"Hypothalamic neuronal histamine as a target of leptin in feeding behavior","volume":"48","author":"Yoshimatsu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2006.10.031_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2005.09.017","article-title":"Effects of histamine H3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice","volume":"50","author":"Jia","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2006.10.031_bib46","first-page":"A230","article-title":"Wake promoting effect of non-imidazolin histamine H3 antagonist in orexin\/ataxin-3 narcoleptic mice","volume":"29","author":"Fujiki","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.bcp.2006.10.031_bib47","unstructured":"Carruthers N. Histamine H3 antagonists: potential applications for the treatment of excessive sleepiness and attention disorders. ASPET Annual Meeting, Symposium in Memoriam, Arthur Hancock, Ph.D. (1949\u20132005). San Francisco, 2006."},{"key":"10.1016\/j.bcp.2006.10.031_bib48","first-page":"1134","article-title":"Effects of a novel, selective, and potent histamine H3 receptor antagonist, GT-2332, on rat sleep\/wakefulness and canine cataplexy","volume":"25","author":"Tedford","year":"1999","journal-title":"Soc Neurosci"},{"key":"10.1016\/j.bcp.2006.10.031_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/smrv.1999.0069","article-title":"Narcolepsy: genetic predisposition and neuropharmacological mechanisms","volume":"4","author":"Nishino","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.bcp.2006.10.031_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(97)01537-0","article-title":"Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus","volume":"788","author":"Alves-Rodrigues","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib51","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1007\/s000110300041","article-title":"Identification of novel H3 receptor (H3R) antagonist with cognition enhancing properties in rats","volume":"52","author":"Fox","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(90)91508-E","article-title":"Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat","volume":"523","author":"Lin","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0166-4328(03)00091-3","article-title":"Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats","volume":"144","author":"Vanni-Mercier","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib54","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2006.10.031_bib55","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2006.10.031_bib56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3565(24)37050-8","article-title":"Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat","volume":"283","author":"Edgar","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib57","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","article-title":"Fos expression in orexin neurons varies with behavioral state","volume":"21","author":"Estabrooke","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2006.10.031_bib58","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.0600451103","article-title":"Altered sleep\u2013wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2006.10.031_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-003-1431-0","article-title":"H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization","volume":"167","author":"Komater","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2006.10.031_bib60","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.bcp.2006.10.031_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2006.10.031_bib62","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1476-5381.1996.tb16086.x","article-title":"Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats","volume":"119","author":"Blandina","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2006.10.031_bib63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00379-5","article-title":"Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup","volume":"131","author":"Fox","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2006.10.031_bib64","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.biopsych.2005.02.002","article-title":"Rodent models of attention-deficit\/hyperactivity disorder","volume":"57","author":"Sagvolden","year":"2005","journal-title":"Biol Psychiatr"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2006.10.031_bib65","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/070674370200601S09","article-title":"Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies","volume":"6","author":"Huss","year":"2002","journal-title":"J Atten Disord"},{"key":"10.1016\/j.bcp.2006.10.031_bib66","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1997"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295206006976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295206006976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T21:29:47Z","timestamp":1736630987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295206006976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0006295206006976"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2006.10.031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}